Loading data…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$35.91M net loss for the year ended January 31, 2026. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| February 2, 2025 – January 31, 2026 | $435,017,000 | March 19, 2026 | 10-K ↗ |
| February 4, 2024 – February 1, 2025 | $467,015,000 | March 19, 2026 | 10-K ↗ |
| January 29, 2023 – February 3, 2024 | $521,815,000 | March 19, 2026 | 10-K ↗ |
| January 30, 2022 – January 28, 2023 | $545,838,000 | March 20, 2025 | 10-K ↗ |
| January 31, 2021 – January 29, 2022 | $505,021,000 | March 21, 2024 | 10-K ↗ |
| February 2, 2020 – January 30, 2021 | $318,946,000 | March 16, 2023 | 10-K ↗ |
| February 3, 2019 – February 1, 2020 | $474,038,000 | March 17, 2022 | 10-K ↗ |
| February 4, 2018 – February 2, 2019 | $473,756,000 | March 19, 2021 | 10-K ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · Retrieved October 13, 2026
Response SHA-256: 31bcec59209c675df05cde415e0fa191f46468da604604176e2378ed41f59860
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.